This week in cannabis, the debate over hemp versus marijuana policy took center stage as the Marijuana Policy Project defended its support for a federal hemp cannabinoid extension. In Massachusetts, a growing coalition of lawmakers publicly urged voters to reject a repeal initiative on the November ballot. Meanwhile, a Minnesota government study found medical marijuana helps people with autism reduce anxiety and depression.
Adam Smith of the Marijuana Policy Project responded this week to an op-ed by Chris Lindsey, a former MPP staffer and now vice president of the American Trade Association for Cannabis and Hemp, criticizing MPP for an alert supporting a federal extension for hemp-derived cannabinoids before a near-total ban takes effect. Smith wrote that the bifurcation of hemp and marijuana is a difficult and problematic issue, noting the two are the same plant, cannabis, and that MPP agrees with a number of the concerns Lindsey raises.
Smith described the division as “at once under- and over-regulated,” writing, “This division, at once under- and over-regulated, is not the cannabis and cannabinoid industry that any of us need.” He said MPP remains 100 percent committed to descheduling the plant and its naturally occurring extracts at the federal level, supporting a single, consistent set of rules for adults, including meaningful testing, truthful labeling and strict age-gating, and believes low-dose drinks and edibles should be legally available to adults anywhere beer or wine are sold or served.
Democratic Gov. Maura Healey and Democratic Congresswoman Ayanna Pressley are both speaking out publicly against Question 8, a November ballot measure seeking to repeal key elements of Massachusetts’ voter-approved marijuana legalization law.
We’ve got to keep recreational marijuana here in Massachusetts,” Healey said on WCVB Boston’s On the Record.
Pressley said in a statement released by the ‘No on 8’ campaign that keeping marijuana legal is both economic justice and racial justice policy, and that repealing legal adult use would undo progress and have devastating impacts.
A new study conducted by state officials in Minnesota found medical marijuana helps people with autism ease their anxiety and depression. The research involved 1,800 patients enrolled in the state’s medical marijuana program and is “one of the largest on record involving autism spectrum disorder (ASD) and medical cannabis patients,” officials said. Of the 88 percent of patients reporting moderate to severe anxiety upon entering the program, more than half reduced their anxiety by 30 percent or more within four months, and 67 percent maintained that reduction for an additional four months.
Audit Finds Gaps In Colorado Marijuana Testing Oversight A Colorado state audit has found significant gaps in the regulatory framework…
Eight Count Indictment Returned in Portland A federal grand jury in Portland, Oregon, returned an eight-count indictment last week against…
Baltimore Mayor Signs Padlock Bill Targeting Illegal Cannabis Shops Baltimore Mayor Brandon Scott signed a bill last week giving the…
Campaign Lets Public Ship THC Drinks To Congress Cannabis beverage company Herb Light is launching a "Cheers Against Prohibition" campaign…
NORML Files Amicus Brief in Sixth Circuit Members of the NORML Legal Committee, led by attorney William Swor of Detroit,…
A Twenty Dollar Lens On A Billion Dollar Economy Buttermilk Press announced the premiere of WEED MONEY on October 10,…